Human immunoglobulin (measles/hepatitis virus infection), Hualan Biological Engineering

人免疫球蛋白（华兰生物工程股份有限公司）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman immunoglobulin (measles/hepatitis virus infection), Hualan Biological Engineering
Drug Alias Namehuman immunoglobulin (intramuscular, measles/hepatitis virus infection)
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPurpura, Thrombocytopenic, IdiopathicHepatitisMeasles
Global Approved IndicationsHepatitisMeasles
Approved Indications in ChinaHepatitisMeasles
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHualan Ankang Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHualan Biological Engineering IncHualan Ankang Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPurpura, Thrombocytopenic, IdiopathicHepatitisMeasles
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB04
Related LinksN/A